NIPPON SHINYAKU CO chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 1,959.02
Dividend & Yield112.00¥ (1.44%)
Beta 0.19
Market capitalization 503.8B
Operating cash flow N/A
ESG Scores unknown

Company description

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Switzerland, and internationally. The company operates through Pharmaceuticals and Functional Food segments. It offers drugs for urological diseases, inflammation and allergies, hematologic malignancies, cardiovascular and metabolic diseases, gastrointestinal disorders, and other diseases. The company's products include Zalutia for urinary disorder caused by benign prostatic; Eviprostat for prostatic hypertrophy; Bladderon for pollakisuria; Estracyt for prostate cancer; Cialis for erectile dysfunction; Vidaza for myelodysplastic syndrome; Cylocide for solid tumor and acute leukemia; CylocideN for relapsed and refractory acute leukemia and malignant lymphoma; Gazyva for humanized anti-CD20 monoclonal antibody; Defiterio sinusoidal obstruction syndrome; and Trisenox and Amnolake for relapsed and refractory acute promyelocytic leukemia. Nippon Shinyaku Co., Ltd.'s products also comprise Uptravi, Adcirca, and Opsumit for pulmonary arterial hypertension; VILTEPSO for muscular dystrophy; Lunabel LD and Lunabel ULD for dysmenorrhea; Erizas, a dry powder inhaler solution for allergic rhinitis; Azunol Gargle liquid, a gargling solution containing azulene; Isobide for oral osmotic diuresis/meniere's disease; Cephadol for vertigo; Livostin for allergic rhinitis and conjunctivitis; Regtect for maintaining alcohol abstinence; and Onetram and Tramal for cancer and chronic pain. In addition, it researches, develops, and markets drugs in the areas of gynecology, otorhinolaryngology, and orthopedics. Further, the company provides functional foods, such as health food ingredients, preservatives, protein preparations, supplements, and spice and condiments. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.

Sector: Healthcare - Industry: Drug Manufacturers—Specialty & Generic

Financial data

Financial Statements

Cashflow Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Change To Liabilities 431M 2.34B -1.41B 2.72B
Total Cashflows From Investing Activities 511M -2.34B -1.56B -10.04B
Net Borrowings
Total Cash From Financing Activities -3.71B -5.66B -6.2B -8.41B
Change To Operating Activities -306M -3.79B 691M -3.04B
Issuance Of Stock
Net Income 16.3B 16.87B 20.7B 24.99B
Change In Cash 12.12B 4.67B 13.58B 2.68B
Effect Of Exchange Rate 9M -72M -40M -188M
Total Cash From Operating Activities 15.31B 12.74B 21.39B 21.32B
Depreciation 3.42B 3.47B 3.55B 4.59B
Change To Account Receivables -6.39B 5.03B 1.72B -2.88B
Other Cashflows From Financing Activities -5M -6M -1.61B -1.61B
Change To Netincome -4.35B -6.24B -6.3B -10.95B
Capital Expenditures -1.35B -1.82B -2.17B -3.14B

Income Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Research Development 16.7B 13.99B 16.1B 22.86B
Income Before Tax 21.54B 22.44B 28.76B 33.3B
Net Income 16.3B 16.87B 20.7B 24.99B
Selling General Administrative 26.07B 27.47B 29.32B 31.26B
Gross Profit 63.76B 63.48B 71.93B 87.29B
Ebit 20.64B 21.67B 26.14B 32.01B
Operating Income 20.64B 21.67B 26.14B 32.01B
Interest Expense -3M -2M -2M -55M
Income Tax Expense 5.22B 5.55B 8.04B 8.3B
Total Revenue 114.72B 116.64B 121.89B 137.48B
Cost Of Revenue 50.95B 53.16B 49.95B 50.19B
Total Other Income ExpenseNet 894M 772M 2.62B 1.3B
Net Income From Continuing Ops 16.32B 16.89B 20.72B 25B
Net Income Applicable To Common Shares 16.3B 16.87B 20.7B 24.99B

Balance Sheet Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Total Liabilities 33.57B 29.26B 34.49B 39.06B
Total Stockholder Equity 134.94B 145.49B 162.25B 180.59B
Other Current Liabilities 13.04B 9.26B 17.51B 8.56B
Total Assets 168.76B 175.02B 197.03B 219.94B
Common Stock 5.17B 5.17B 5.17B 5.17B
Other Current Assets 2.66B 3.4B 2.97B 2.74B
Retained Earnings 121.68B 132.89B 147.39B 165.3B
Treasury Stock 3.64B 2.98B 5.24B 5.66B
Cash 31.52B 36.01B 47.77B 60.57B
Total Current Liabilities 25.41B 24.96B 31.51B 32.03B
Other Stockholder Equity 6.11B 5.46B 7.72B 8.14B
Property, Plant, and Equipment 20.57B 20.94B 21.31B 31.06B
Total Current Assets 110.72B 121.92B 139.09B 149.72B
Net Tangible Assets 134.52B 144.94B 161.58B 166.53B
Net Receivables 46.55B 41.52B 39.8B 43.18B
Accounts Payable 7.99B 11.21B 9.54B 21.02B


Insider Transactions

Here are the insider transactions of stock shares related to NIPPON SHINYAKU CO:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to NIPPON SHINYAKU CO. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on NIPPON SHINYAKU CO

Here is the result of two systematic investment strategies applied to NIPPON SHINYAKU CO. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on NIPPON SHINYAKU CO

The following chart shows the equity curve of the two systematic investment strategies applied to NIPPON SHINYAKU CO:

NIPPON SHINYAKU CO automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 20.0% on the backtest period.

Performance at glance

Performance

20.0 %

Latent gain

2580.0 ¥

Invested capital

12900.0 ¥

Annualized return

4.76 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on NIPPON SHINYAKU CO

This is the result of two momentum investment strategies applied to NIPPON SHINYAKU CO. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on NIPPON SHINYAKU CO

The following chart shows all the entries opened by the momentum investment system on NIPPON SHINYAKU CO:

NIPPON SHINYAKU CO momentum entries
  • The first momentum investment strategy would give 34.38% of return on NIPPON SHINYAKU CO. That represents 1980.0¥ of latent gain with 5760.0¥ of employed capital.
  • The second momentum investment strategy would give 7.65% of return on NIPPON SHINYAKU CO. That represents 550.0¥ of latent gain with 7190.0¥ of employed capital.
Performance at glance (1Q Momentum)

Performance

34.38 %

Latent gain

1980.0 ¥

Invested capital

5760.0 ¥

Annualized return

-1.42 %
Performance at glance (2Q Momentum)

Performance

7.65 %

Latent gain

550.0 ¥

Invested capital

7190.0 ¥

Annualized return

2.06 %

Momentum equity curve on NIPPON SHINYAKU CO

The following chart shows the equity curve of the two momentum strategies applied to NIPPON SHINYAKU CO:

NIPPON SHINYAKU CO momentum equity

Note: the dividends potentially given by NIPPON SHINYAKU CO are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on NIPPON SHINYAKU CO

The following chart shows the employed capital evolution of the two momentum strategies on NIPPON SHINYAKU CO since the beginning:

NIPPON SHINYAKU CO

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250¥, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000¥.


Buy the dip strategy result on NIPPON SHINYAKU CO

Buy the dip entry openings on NIPPON SHINYAKU CO

NIPPON SHINYAKU CO

The performance achieved by the robo-advisor on NIPPON SHINYAKU CO is -3.13%. That represents -250.0$ of latent gain with 7990.0¥ of employed capital. The following chart shows NIPPON SHINYAKU CO stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of NIPPON SHINYAKU CO, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

-3.13 %

Latent gain

-250.0 ¥

Invested capital

7990.0 ¥

Annualized return

-1.42 %

Equity curve of the strategy applied to NIPPON SHINYAKU CO

The following chart shows the result of the investment strategy applied to NIPPON SHINYAKU CO:

NIPPON SHINYAKU CO

Note: the dividends potentially given by NIPPON SHINYAKU CO are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on NIPPON SHINYAKU CO

The following chart shows the employed capital evolution since the beginning of the investment strategy on NIPPON SHINYAKU CO:

NIPPON SHINYAKU CO

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on NIPPON SHINYAKU CO

In this section, I will compare the three previous investment strategies applied to NIPPON SHINYAKU CO.

Equity curve comparison on NIPPON SHINYAKU CO

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

NIPPON SHINYAKU CO investment strategy comparison

Employed capital comparison on NIPPON SHINYAKU CO

NIPPON SHINYAKU CO investment comparison

Performance comparison on NIPPON SHINYAKU CO

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 20.0% 2580.0¥ 12900.0¥ 4.76%
Momentum 1 quarter 34.38% 1980.0¥ 5760.0¥ 8.68%
Momentum 2 quarters 7.65% 550.0¥ 7190.0¥ 2.06%
Non-directional -3.13% -250.0¥ 7990.0¥ -1.42%
Annualized return comparison

Automatic investment

4.76 %

Momentum 1Q

2.06 %

Momentum 2Q

2.06 %

Non-directional

-1.42 %

Correlated stocks

Here are the most positively and negatively correlated stocks with NIPPON SHINYAKU CO:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between NIPPON SHINYAKU CO and the other stocks. There may be false positives or some missing correlated stocks. If the price of NIPPON SHINYAKU CO does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name NIPPON SHINYAKU CO
Country Japan
City Kyoto
Address 14, Nishinosho-Monguchi-cho
Phone 81 7 5321 1111
Website www.nippon-shinyaku.co.jp
FullTime employees 2125
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Exchange XTKS
Ticker 4516.XTKS
Market www.jpx.co.jp

NIPPON SHINYAKU CO ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown